CURE® Summer 2021 Issue

As patients aged 65 or older receive a diagnosis of cancer, their treatment course and priorities may differ from their younger counterparts.

Katie Brown, senior vice president of survivorship and support for LUNGevity Foundation, wrote about a program for patients to gain knowledge from survivors.

In its Speaking Out video series, on behalf of Aim at Melanoma, CURE ® spoke with Dr. Sunandana Chandra about emerging therapies in melanoma.

Having a pet to care for may motivate patients to exercise and be positive when undergoing cancer treatment.

Patients and their caregivers can navigate a terminal cancer diagnosis while keeping dignity intact.

Patients can now prioritize whether durable responses to treatment or avoiding certain side effects are more valuable to them.

Increasingly, researchers are playing matchmaker between patients with metastatic cancer and targeted drugs via studies called basket trials.

Newer cancer therapies easily cost upward of $100,000. Why so much? Who sets the prices and what can patients do if they can't afford them?